An interventional study of VeNS and Placebo device in Insomnia, Sleep and Sleep Disorders, Circadian Rhythm, sponsored by Neurovalens Ltd.. Completed at 1 site in India. Open to participants aged 18 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-10-21.
Sponsored by Neurovalens Ltd. · Not applicable, Interventional, and Treatment
How we know · 5 judgments
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Sleep Initiation and Maintenance Disorders with a site in India — 2 open to participants now, 2 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · India.
Among the 10 studies in Sleep Initiation and Maintenance Disorders with a site in India, this one is the only one that started in 2020, is one of 8 with no phase, and was the 3rd registered.
2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.
Browse Sleep Initiation and Maintenance Disorders studies →2 of the 10 studies in Sleep Initiation and Maintenance Disorders with a site in India are open now. Recruiting first, the newest first:
Aditi Bunker · Sites in India, Burkina Faso, Fiji and 2 more countries
Ages 18+ · Healthy volunteers
All India Institute of Medical Sciences · Sites in India
Ages 18–65
A study can be open while its sites in India have not opened yet or have stopped. Only those recruiting at a site in India →
Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.
This study: 18 Years to 24 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 1 started in 2020.
This study's enrollment of 80 is above the median of 68 across 2,363 interventional studies indexed under Sleep Initiation and Maintenance Disorders.
Median enrollment 100 across the 9 interventional studies, 200 across the 1 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 10 have an industry lead sponsor. The 8 most frequent:
Neurovalens Ltd. is the lead sponsor of 20 studies on the registry; 1 is open to participants now.
Neurovalens Ltd. has 4 studies filed under Sleep Initiation and Maintenance Disorders — fewer than ten, so there is no comparison to draw.
1 of the studies in Sleep Initiation and Maintenance Disorders with a site in India that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06579950Aditi BunkerAssessing the Effects of Cool Roofs on Indoor Environments and Health | 2027-09-30 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Sleep Initiation and Maintenance Disorders with a site in India, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A randomized, double blind sham controlled clinical trial to evaluate the efficacy of vestibular nerve stimulation (VeNS) compared to a sham control a as a means of improving sleep as measured by ISI scores and EEG recordings
The purpose of this investigation device study is to collect data that will be used to design appropriate pivotal studies that can be used for regulatory submissions, primarily in the United States of America (USA), but it may also be used to support submissions in other regions, including the European Union (EU).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The VeSTAL device will be placed on the head in a manner analogous to headphones and will deliver a small electrical current to the skin behind the ears, over the mastoid processes. Participants will be advised to use the device at home for 1 hour per day in the period immediately prior to sleep onset.
Device: VeNS
The sham device looks identical to the active device and interacts with the app in a similar manner to the active device. However, it does not deliver vestibular stimulation to users. device will be placed on the head in a manner analogous to headphones and will deliver a small electrical current to the skin behind the ears, over the mastoid processes. Participants will be advised to use the device at home for 1 hour per day in the period immediately prior to sleep onset.
Device: Placebo device
Non-invasive electrical vestibular nerve stimulation
Sham non-invasive electrical vestibular nerve stimulation
Change in Insomnia Severity Index (ISI) Scores
ISI scores will be measured during the study and will be compared to baseline readings taken prior to intervention. Insomnia Severity Index scores range from 0 to 28. Scores greater than 15 indicate clinical insomnia.
Time frame: Day 0, Day 7, Day 14, Day 21, Day 28
EEG Assessment
EEG power in alpha band
Time frame: Day 0, Day 28
Depression Anxiety Stress Scales (DASS) Assessment
DASS will be measured during the study and will be compared to baseline readings taken prior to intervention. DASS is scored from 0 to 42 with higher scores indicating more symptoms.
Time frame: Day 0, Day 7, Day 14, Day 21, Day 28
WHO Quality of Life (WHOQOL) Assessment
QOL will be measured during the study and will be compared to baseline readings taken prior to intervention. WHOQOL is scored from 0 to 100 with higher scores indicating a higher quality of life.
Time frame: Day 0, Day 7, Day 14, Day 21, Day 28
Plan to share: No — Data will be transferred in an encrypted PDF format. Trial staff will be given direction on how to share the trial data and given access to one specific section of a controlled cloud service which is controlled via role based access. Once they have authenticated with the service and the service verifies that they have the correct role to access the system they will be directed to a single webpage within the application where they will be able to upload the encrypted PDF. This PDF is generated on the fly and is therefore not stored in another location that could become compromised. Generating the PDF on the fly means that the source data is extracted from the database, processed and delivered in the context of a single request. These data will be transferred for each subject when they complete participation in the study.
No publications or documents are linked to this record.
Ran from Mar 2020 to primary completion in Jul 2022, 28 months.
Of 78 industry-sponsored interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 23. This study's 28 months is above that.
Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sleep Initiation and Maintenance Disorders →